Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Dr. Mittie DoyleChief Medical Officer | -679.00 | 5.40k | Derivative Exercise and Sale | 8.04 - 16.00 | 3.62k | - |
| 2026-05-15 | Dr. Mittie DoyleChief Medical Officer | -3.00k | 18.33k | Derivative Exercise and Sale | 12.65 - 18.76 | 3.62k | - |
| 2026-05-07 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | -18.61k | 264.99k | Derivative Exercise and Sale | 9.88 - 24.12 | 423.00 | - |
| 2026-05-06 | Mr. Paul C. VarkiChief Legal Officer | -75.06k | 573.29k | Derivative Exercise and Sale | 8.04 - 23.71 | 3.63k | - |
| 2026-05-06 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | -47.00k | 570.84k | Derivative Exercise and Sale | 8.04 - 22.57 | 423.00 | - |
| 2026-05-05 | Dr. Mittie DoyleChief Medical Officer | -108.23k | 996.41k | Derivative Exercise and Sale | 8.04 - 22.88 | 3.62k | - |
| 2026-05-06 | Mr. Mitchell ChanIndependent Director | -3.17k | 72.46k | Automatic Disposition | 22.88 | 3.17k | -50.01% |
| 2026-04-29 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | -16.92k | 222.59k | Automatic Disposition | 13.09 - 13.23 | 423.00 | -97.56% |
| 2026-04-06 | Dr. Mittie DoyleChief Medical Officer | -3.97k | 21.29k | Derivative Exercise and Sale | 12.65 - 18.01 | 3.62k | - |
| 2026-04-01 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | -15.96k | 270.59k | Automatic Disposition | 15.86 - 17.57 | 17.34k | -47.93% |
| 2026-04-01 | Dr. Mittie DoyleChief Medical Officer | -679.00 | 5.40k | Derivative Exercise and Sale | 8.04 - 16.00 | 3.62k | - |
| 2026-03-28 | Ms. Samantha Scollard TruexIndependent Director | 3.17k | 0.00 | Derivative Exercise and Retained Stock | - | 6.33k | 99.97% |
| 2026-03-28 | Mr. Aaron KantoffIndependent Director | 3.17k | 0.00 | Derivative Exercise and Retained Stock | - | 6.33k | 99.97% |
| 2026-03-28 | Dr. Gilla KaplanIndependent Director | 3.17k | 0.00 | Derivative Exercise and Retained Stock | - | 6.33k | 99.97% |
| 2026-03-28 | Dr. Garry A. NeilPresident, CEO & Director | 42.97k | 0.00 | Derivative Exercise and Retained Stock | - | 90.11k | 91.16% |
| 2026-03-28 | Dr. Garry A. NeilPresident, CEO & Director | -21.89k | 304.08k | Derivative Exercise and Sale | 13.89 | 90.11k | - |
| 2026-03-28 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | 15.96k | 0.00 | Derivative Exercise and Retained Stock | - | 33.30k | 92.05% |
| 2026-03-28 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | -8.24k | 114.47k | Derivative Exercise and Sale | 13.89 | 33.30k | - |
| 2026-03-28 | Mr. Mitchell ChanIndependent Director | 3.17k | 0.00 | Derivative Exercise and Retained Stock | - | 6.33k | 99.97% |
| 2026-03-28 | Dr. Jonathan GoldmanIndependent Director | 3.17k | 0.00 | Derivative Exercise and Retained Stock | - | 3.17k | - |
| 2026-03-16 | Dr. Mittie DoyleChief Medical Officer | -25.49k | 116.76k | Derivative Exercise and Sale | 8.04 - 16.15 | 3.62k | - |
| 2025-12-10 | Dr. Mittie DoyleChief Medical Officer | -1.01k | 4.15k | Sale to Issuer | 4.10 | 3.62k | -21.86% |
| 2025-12-10 | Mr. Paul C. VarkiChief Legal Officer | -1.02k | 4.17k | Sale to Issuer | 4.10 | 3.63k | -21.85% |
| 2025-12-10 | Ms. Jennifer RileyChief Strategy Officer | -637.00 | 2.61k | Sale to Issuer | 4.10 | 2.66k | -19.35% |
| 2025-12-10 | Mr. Christopher Ryan SullivanCFO & Head of Investor relations | -155.00 | 635.50 | Sale to Issuer | 4.10 | 17.34k | -0.89% |
| 2025-11-14 | Dr. Jonathan GoldmanIndependent Director | -8.20k | 36.63k | Derivative Exercise and Sale | 9.88 - 14.35 | 0.00 | - |
| 2025-11-14 | Dr. Jonathan GoldmanIndependent Director | -3.17k | 45.29k | 売り | 14.30 | 0.00 | -100.00% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
